Objective:

To highlight concerns regarding poor metabolite identification in metabolomics and its implications for both research and clinical applications.

Key Findings:

• Poor metabolite identification leads to implausible compound assignments and insufficiently validated results, which can mislead future research.
• LC-MS technology generates large datasets, but inexperienced users may misinterpret database matches as definitive identifications, risking erroneous conclusions.
• Only a small proportion of detected metabolites can be confidently identified without proper validation, highlighting the need for rigorous checks.
• Misidentified metabolites can distort biological interpretations and influence future studies and clinical hypotheses, potentially leading to flawed research.
• There is a need for stronger validation practices and greater awareness of best practices in the field to ensure reliable findings.

Interpretation:

The field of metabolomics is at risk of propagating incorrect findings due to inadequate validation and interpretation of data, which can have serious implications for research and clinical outcomes.

Limitations:

• The rapid rise of metabolomics has led to an influx of researchers without strong backgrounds in the field, complicating the validation process.
• The complexity of the metabolome, influenced by various factors such as environment, diet, microbiome, and medication, complicates metabolite identification and increases the risk of errors.

Conclusion:

While not yet a crisis, the field of untargeted metabolomics faces significant challenges that require urgent improvements in validation and interpretation practices to prevent future issues.